4D Molecular Therapeutics (FDMT) Prepaid Assets (2019 - 2025)
Historic Prepaid Assets for 4D Molecular Therapeutics (FDMT) over the last 7 years, with Q3 2025 value amounting to $7.3 million.
- 4D Molecular Therapeutics' Prepaid Assets fell 1749.58% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 1749.58%. This contributed to the annual value of $10.1 million for FY2024, which is 2033.27% up from last year.
- 4D Molecular Therapeutics' Prepaid Assets amounted to $7.3 million in Q3 2025, which was down 1749.58% from $10.1 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Prepaid Assets registered a high of $11.1 million during Q1 2025, and its lowest value of $3.3 million during Q3 2021.
- Over the past 5 years, 4D Molecular Therapeutics' median Prepaid Assets value was $7.4 million (recorded in 2023), while the average stood at $7.5 million.
- Per our database at Business Quant, 4D Molecular Therapeutics' Prepaid Assets skyrocketed by 9027.9% in 2021 and then tumbled by 1772.71% in 2022.
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Prepaid Assets stood at $8.5 million in 2021, then dropped by 17.73% to $7.0 million in 2022, then rose by 20.11% to $8.4 million in 2023, then rose by 20.33% to $10.1 million in 2024, then decreased by 27.26% to $7.3 million in 2025.
- Its Prepaid Assets stands at $7.3 million for Q3 2025, versus $10.1 million for Q2 2025 and $11.1 million for Q1 2025.